INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,115 | -1.4% | 225 | +27.1% | 0.00% | 0.0% |
| Q2 2023 | $7,218 | +127.8% | 177 | +108.2% | 0.00% | – |
| Q1 2023 | $3,168 | -21.7% | 85 | -26.7% | 0.00% | – |
| Q4 2022 | $4,047 | -68.9% | 116 | -51.5% | 0.00% | -100.0% |
| Q3 2022 | $13,000 | +18.2% | 239 | +9.6% | 0.00% | 0.0% |
| Q2 2022 | $11,000 | -35.3% | 218 | -5.2% | 0.00% | -33.3% |
| Q1 2022 | $17,000 | -76.1% | 230 | -61.7% | 0.00% | -72.7% |
| Q4 2021 | $71,000 | +1083.3% | 600 | +1150.0% | 0.01% | +450.0% |
| Q3 2021 | $6,000 | -25.0% | 48 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $8,000 | -33.3% | 48 | -66.9% | 0.00% | -33.3% |
| Q1 2021 | $12,000 | +200.0% | 145 | -22.5% | 0.00% | +200.0% |
| Q2 2020 | $4,000 | – | 187 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |